MedTrace Logo

Linking Churches With Parks to Increase Physical Activity Among Latinos

NCT03858868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 925

Last updated 2025-06-08

No results posted yet for this study

Summary

This study is a cluster randomized controlled trial of a multi-level intervention that links Latino Catholic churches (n=14) with their local parks to increase physical activity among Latino parishioners (n=1204) in Los Angeles. The study will examine the impact of the intervention on Latino parishioners' PA and health-related outcomes; explore differences in the intervention's effectiveness by gender; and evaluate factors associated with implementation for future dissemination. If successful, the intervention has the potential for sustainability and scale-up across the largest diocese in the U.S. and potentially across the nation.

Conditions

  • Physical Activity

Interventions

BEHAVIORAL

Church and park-based intervention

Multiple components involving motivational messages and concrete opportunities for physical activity at the church and the local park.

BEHAVIORAL

Standard health education on physical activity

Participants will receive publicly available brochures, tip sheets, etc. about physical activity

Sponsors & Collaborators

  • California State University, Los Angeles

    collaborator OTHER

  • San Diego State University

    collaborator OTHER

  • RAND

    lead OTHER

Principal Investigators

  • Kathryn P Derose, PhD, MPH · RAND

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-03
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03858868 on ClinicalTrials.gov